Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
27.06. | With China approval, Lilly and Innovent's mazdutide breaks into new class for GLP-1 obesity drugs | ||
27.06. | FDA removes CAR-T access barrier in move set to boost cancer immunotherapy uptake | ||
27.06. | After Novo and Lilly resolved GLP-1 shortages, where does the compounding industry stand? Experts weigh in | ||
27.06. | Ocular Therapeutix sharpens focus with retina-centric rebrand | ||
26.06. | With thimerosal vote, RFK Jr.'s ACIP shows willingness to take on vaccine convention | ||
26.06. | GSK, Gilead, Novo Nordisk join other Big Pharmas in honoring 2025 LGBTQ+ Pride month | ||
26.06. | Incyte waves goodbye to longtime CEO Hervé Hoppenot as new appointment raises M&A hopes | ||
26.06. | CDC immunization advisory panel endorses Merck's new RSV shot, but not without dissent | ||
26.06. | Vor Bio's surprise $4B revival deal for RemeGen's autoimmune drug triggers divergent stock reactions | ||
26.06. | Emergent lands $62.4M upgrade to botulism antitoxin supply pact with US | ||
26.06. | Abbott in partnership focused on producing pharmaceuticals in Abu Dhabi | ||
26.06. | Pfizer's hemophilia drug Hympavzi notches phase 3 win as pharma eyes label expansion | ||
25.06. | Saatchi & Saatchi Wellness nets new president plus creative and client execs | ||
25.06. | Uptake of Gilead's Yeztugo will be swift, analyst says after discussion with HIV doc | ||
25.06. | New-look ACIP, down a member and homing in on 'long-settled safety topics,' kicks off controversial vaccine meeting | ||
25.06. | GSK, Bharat Biotech to slash the price of first malaria vaccine to less than $5 per dose by 2028 | ||
25.06. | FDA investigates patient deaths after treatment with Sarepta's Duchenne gene therapy Elevidys | ||
25.06. | Novo Nordisk questioned over controversial Spanish obesity awareness campaign | ||
24.06. | Amarin sells heart pill Vascepa's rights in Europe to Recordati amid restructuring bid | ||
24.06. | Cassidy, key in RFK Jr.'s HHS confirmation, calls for deferral of CDC's vaccine meeting | ||
24.06. | London calling: The Bloc expands into UK with new office, executive hires | ||
24.06. | Craig Romanok follows Omnicom-to-Publicis path, taking up chief commercial officer post at Digitas | ||
24.06. | AstraZeneca, Daiichi's Datroway scores its 2nd FDA approval-this time in lung cancer subset | ||
23.06. | UK lays out strategy to become a top 3 life sciences economy by 2035 | ||
23.06. | Reckitt recruits Serena Williams for initiative to support 200 women-led health startups by 2030 |